APOB and familial hypercholesterolemia: Next, to demonstrate the general utility of the CEM effect on 2′,4′-BNA-based ASOs, we developed ASOs targeting endogenous apolipoprotein B (ApoB) mRNA, a known drug target for homozygous familial hypercholesterolemia.